Bulk Manufacturer of Controlled Substances Application: Olon Ricerca Bioscience LLC, 41419-41420 [2023-13471]
Download as PDF
<![CDATA[
41419
Federal Register / Vol. 88, No. 121 / Monday, June 26, 2023 / Notices
The company plans to bulk
manufacture the listed controlled
substances for the internal use
intermediates or for sale to its
customers. The company plans to
manufacture small quantities of the
above-listed controlled substances as
radiolabeled compounds for
biochemical research. No other
activities for these drug codes are
authorized for this registration.
ACTION:
Notice of application.
Arista Biologicals has applied
to be registered as a bulk manufacturer
of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before August 25, 2023. Such
persons may also file a written request
for a hearing on the application on or
before August 25, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
SUMMARY:
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–13473 Filed 6–23–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1203]
Bulk Manufacturer of Controlled
Substances Application: Arista
Biologicals
Drug Enforcement
Administration, Justice.
AGENCY:
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
In
accordance with 21 CFR 1301.33(a), this
is notice that on April 6, 2023, Arista
Biologicals, 1101 Hamilton Street,
Allentown, Pennsylvania 18101–1043,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug code
4-Anilino-N-Phenethyl-4-Piperidine (ANPP) ...........................................................................................................................
Norfentanyl (N-phenyl-N-(piperidin-4-yl)propionamide) ..........................................................................................................
The company plans to bulk
manufacture the listed controlled
substances for internal use as
intermediates for formulation and
analytical development purposes. No
other activities for these drug codes are
authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–13466 Filed 6–23–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1220]
Bulk Manufacturer of Controlled
Substances Application: Olon Ricerca
Bioscience LLC
Drug Enforcement
Administration, Justice.
ddrumheller on DSK120RN23PROD with NOTICES1
AGENCY:
ACTION:
Notice of application.
Olon Ricerca Bioscience LLC,
has applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before August 25, 2023. Such
persons may also file a written request
for a hearing on the application on or
before August 25, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
SUMMARY:
In
accordance with 21 CFR 1301.33(a), this
is notice that on May 17, 2023, Olon
Ricerca Bioscience LLC, 7528 Auburn
Road, Concord Township, Ohio 44077–
9176 applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Amphetamine .................................................................................................................................................................................
Lisdexamfetamine ..........................................................................................................................................................................
19:33 Jun 23, 2023
Jkt 259001
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
II
II
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
Controlled substance
VerDate Sep<11>2014
8333
8366
Schedule
E:\FR\FM\26JNN1.SGM
26JNN1
Drug
code
Schedule
1100
1205
II
II
41420
Federal Register / Vol. 88, No. 121 / Monday, June 26, 2023 / Notices
The company plans to bulk
manufacture the listed controlled
substances for distribution to their
customers. No other activities for these
drug codes are authorized for this
registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–13471 Filed 6–23–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF LABOR
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; Student
Safety Assessment of Job Corps
Centers
Notice of availability; request
for comments.
ACTION:
The Department of Labor
(DOL) is submitting this Employment
and Training Administration (ETA)sponsored information collection
request (ICR) to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995
(PRA). Public comments on the ICR are
invited.
DATES: The OMB will consider all
written comments that the agency
receives on or before July 26, 2023.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
Comments are invited on: (1) whether
the collection of information is
necessary for the proper performance of
the functions of the Department,
including whether the information will
have practical utility; (2) the accuracy of
the agency’s estimates of the burden and
cost of the collection of information,
including the validity of the
methodology and assumptions used; (3)
ways to enhance the quality, utility and
clarity of the information collection; and
(4) ways to minimize the burden of the
collection of information on those who
are to respond, including the use of
automated collection techniques or
other forms of information technology.
FOR FURTHER INFORMATION CONTACT:
Nicole Bouchet by telephone at 202–
693–0213, or by email at DOL_PRA_
PUBLIC@dol.gov.
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
19:33 Jun 23, 2023
Jkt 259001
The
Department of Labor’s Office of Job
Corps conducts a Student Safety
Assessment. Thes collection of
information through this assessment is
necessary for program evaluation to
gauge active students’ sense of safety
and security at centers. For additional
substantive information about this ICR,
see the related notice published in the
Federal Register on February 7, 2023
(88 FR 7997).
This information collection is subject
to the PRA. A Federal agency generally
cannot conduct or sponsor a collection
of information, and the public is
generally not required to respond to an
information collection, unless the OMB
approves it and displays a currently
valid OMB Control Number. In addition,
notwithstanding any other provisions of
law, no person shall generally be subject
to penalty for failing to comply with a
collection of information that does not
display a valid OMB Control Number.
See 5 CFR 1320.5(a) and 1320.6.
DOL seeks PRA authorization for this
information collection for three (3)
years. OMB authorization for an ICR
cannot be for more than three (3) years
without renewal. The DOL notes that
information collection requirements
submitted to the OMB for existing ICRs
receive a month-to-month extension
while they undergo review.
Agency: DOL–ETA.
Title of Collection: Student Safety
Assessment of Job Corps Centers.
OMB Control Number: 1205–0542.
Affected Public: Private Sector—
Individuals or Households.
Total Estimated Number of
Respondents: 33,906.
Total Estimated Number of
Responses: 230,072.
Total Estimated Annual Time Burden:
57,518 hours.
Total Estimated Annual Other Costs
Burden: $0.
SUPPLEMENTARY INFORMATION:
(Authority: 44 U.S.C. 3507(a)(1)(D))
Nicole Bouchet,
Senior PRA Analyst.
[FR Doc. 2023–13468 Filed 6–23–23; 8:45 am]
BILLING CODE 4510–26–P
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
DEPARTMENT OF LABOR
Office of Workers’ Compensation
Programs
Agency Information Collection
Activities; Comment Request;
Roentgenographic Interpretation (CM–
933), Roentgenographic Quality
Rereading (CM–933b), Medical History
and Examination for Coal Mine
Workers’ Pneumoconiosis (CM–988),
Report of Arterial Blood Gas Study
(CM–1159), and Report of Ventilatory
Study (CM–2907)
ACTION:
Notice.
The Department of Labor
(DOL) is soliciting comments
concerning a proposed extension for the
authority to conduct the information
collection request (ICR) titled,
‘‘Roentgenographic Interpretation’’
(Form CM–933), ‘‘Roentgenographic
Quality Rereading’’ (Form CM–933a),
‘‘Medical History and Examination for
Coal Mine Workers’ Pneumoconiosis’’
(Form CM–988 and CM–988a), ‘‘Report
of Arterial Blood Gas Study’’ (Form
CM–1159), and ‘‘Report of Ventilatory
Study’’ (Form CM–2907). This comment
request is part of continuing
Departmental efforts to reduce
paperwork and respondent burden in
accordance with the Paperwork
Reduction Act of 1995 (PRA).
DATES: Consideration will be given to all
written comments received by August
25, 2023.
ADDRESSES: A copy of this ICR with
applicable supporting documentation;
including a description of the likely
respondents, proposed frequency of
response and estimated total burden
may be obtained free by contacting
Anjanette Suggs by telephone at 202–
354–9660 or by email at
suggs.anjanette@dol.gov.
Submit written comments about this
ICR by mail or courier to the U.S.
Department of Labor, Office of Workers’
Compensation Program, Division of Coal
Mine Workers’ Compensation, Room S–
3323, 200 Constitution Avenue NW,
Washington, DC 20210; by email:
suggs.anjanette@dol.gov.
FOR FURTHER INFORMATION CONTACT:
Anjanette Suggs by telephone at 202–
354–9660 or by email at
suggs.anjanette@dol.gov.
SUPPLEMENTARY INFORMATION: The DOL,
as part of continuing efforts to reduce
paperwork and respondent burden,
conducts a pre-clearance consultation
program to provide the general public
and Federal agencies an opportunity to
comment on proposed and/or
continuing collections of information
SUMMARY:
E:\FR\FM\26JNN1.SGM
26JNN1
]]>Agencies
[Federal Register Volume 88, Number 121 (Monday, June 26, 2023)]
[Notices]
[Pages 41419-41420]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-13471]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1220]
Bulk Manufacturer of Controlled Substances Application: Olon
Ricerca Bioscience LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Olon Ricerca Bioscience LLC, has applied to be registered as a
bulk manufacturer of basic class(es) of controlled substance(s). Refer
to SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
August 25, 2023. Such persons may also file a written request for a
hearing on the application on or before August 25, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on May 17, 2023, Olon Ricerca Bioscience LLC, 7528
Auburn Road, Concord Township, Ohio 44077-9176 applied to be registered
as a bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Amphetamine............................. 1100 II
Lisdexamfetamine........................ 1205 II
------------------------------------------------------------------------
[[Page 41420]]
The company plans to bulk manufacture the listed controlled
substances for distribution to their customers. No other activities for
these drug codes are authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-13471 Filed 6-23-23; 8:45 am]
BILLING CODE P
